Association of Genetic Variants Related to Serum Calcium Levels With Coronary Artery Disease and Myocardial Infarction

Size: px
Start display at page:

Download "Association of Genetic Variants Related to Serum Calcium Levels With Coronary Artery Disease and Myocardial Infarction"

Transcription

1 Research JAMA Original Investigation Association of Genetic Variants Related to Serum Calcium Levels With Coronary Artery Disease and Myocardial Infarction Susanna C. Larsson, PhD; Stephen Burgess, PhD; Karl Michaëlsson, MD, PhD IMPORTANCE Serum calcium has been associated with cardiovascular disease in observational studies and evidence from randomized clinical trials indicates that calcium supplementation, which raises serum calcium levels, may increase the risk of cardiovascular events, particularly myocardial infarction. Supplemental content OBJECTIVE To evaluate the potential causal association between genetic variants related to elevated serum calcium levels and risk of coronary artery disease (CAD) and myocardial infarction using mendelian randomization. DESIGN, SETTING, AND PARTICIPANTS The analyses were performed using summary statistics obtained for single-nucleotide polymorphisms (SNPs) identified from a genome-wide association meta-analysis of serum calcium levels (N = up to individuals) and from the Coronary Artery Disease Genome-wide Replication and Meta-analysis Plus the Coronary Artery Disease Genetics (CardiogramplusC4D) consortium s 1000 genomes-based genome-wide association meta-analysis (N = up to individuals) that included cases (individuals with CAD and myocardial infarction) and noncases, with baseline data collected from 1948 and populations derived from across the globe. The association of each SNP with CAD and myocardial infarction was weighted by its association with serum calcium, and estimates were combined using an inverse-variance weighted meta-analysis. EXPOSURES Genetic risk score based on genetic variants related to elevated serum calcium levels. MAIN OUTCOMES AND MEASURES Co-primary outcomes were the odds of CAD and myocardial infarction. RESULTS Among the mendelian randomized analytic sample of individuals ( CAD cases [approximately 70% with myocardial infarction] and noncases), the 6 SNPs related to serum calcium levels and without pleiotropic associations with potential confounders were estimated to explain about 0.8% of the variation in serum calcium levels. In the inverse-variance weighted meta-analysis (combining the estimates of the 6 SNPs), the odds ratios per 0.5-mg/dL increase (about 1 SD) in genetically predicted serum calcium levels were 1.25 (95% CI, ; P =.003) for CAD and 1.24 (95% CI, ; P =.009) for myocardial infarction. CONCLUSIONS AND RELEVANCE A genetic predisposition to higher serum calcium levels was associated with increased risk of CAD and myocardial infarction. Whether the risk of CAD associated with lifelong genetic exposure to increased serum calcium levels can be translated to a risk associated with short-term to medium-term calcium supplementation is unknown. JAMA. 2017;318(4): doi: /jama Author Affiliations: Unit of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (Larsson); MRC Biostatistics Unit, University of Cambridge, United Kingdom (Burgess); Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom (Burgess); Department of Surgical Sciences, Uppsala University, Uppsala, Sweden (Michaëlsson). Corresponding Author: Susanna C. Larsson, PhD, Unit of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, SE Stockholm, Sweden (susanna.larsson@ki.se). (Reprinted) 371

2 Research Original Investigation Genetic Variants in Serum Calcium and Coronary Artery Disease Calcium has a vital role in many biological processes in the body such as nerve transmission, blood clotting, blood pressure regulation, enzyme activation, hormone regulation, and muscle contraction. Observational studies have suggested that serum calcium levels are positively associated with risk of cardiovascular disease, including myocardial infarction. 1,2 Moreover, evidence from randomized clinical trials indicates that calcium supplementation, which results in an acute and sustained elevation in serum calcium, 3,4 may modestly increase the risk of cardiovascular events, particularly myocardial infarction. 5 However, it remains unclear whether lifelong elevated serum calcium may be causally associated with coronary artery disease (CAD) risk. Nationally representative data show that one-fifth of US adults use calcium supplements, 6 and the proportion is even higher among middle-aged and older women and individuals with disabilities, with more than half of this group being regular calcium supplement users. 7-9 Because of the widespread use of calcium supplements, any association between raised serum calcium and CAD risk by a high calcium intake could have clinical and public health implications. The findings of an elevated risk of cardiovascular events with calcium supplement use 5 have been debated in recent years without consensus being reached Genetic variants that have a specific influence on possible risk factors can be used to assess associations with explicit outcomes. 13 This method, known as mendelian randomization, avoids some of the limitations of observational studies (because genetic information should be free from confounding) and is not affected by disease status, thereby avoiding reverse causation bias. 13 Hence, genetic variants that influence serum calcium levels could serve as instrumental variables (proxies) to determine the association of lifelong elevated serum calcium with CAD risk. We conducted a mendelian randomization study to investigate the association of serum calcium with CAD and myocardial infarction. Methods Design and Data Sources The mendelian randomization approach builds upon 3 principal assumptions (Figure 1). 15 First, the genetic variants utilized as instrumental variables should be associated with the risk factor. Second, the genetic variants should not be associated with confounders. Third, the genetic variants should affect the risk of the outcome through the risk factor, not via other pathways. This study involved analysis of publicly available, deidentified data; specific ethical review and informed consent had been obtained in all of the original studies. This mendelian randomization study was designed to use summary statistics from large-scale genome-wide association studies (GWAS) (Figure 2). GWAS identified 7 singlenucleotide polymorphisms (SNPs) associated with serum calcium levels in a meta-analysis of individuals of Key Points Question Are genetically elevated serum calcium levels associated with an increased risk of coronary artery disease or myocardial infarction? Findings In this mendelian randomization study including cases of coronary artery disease and noncases, genetically elevated serum calcium levels were associated with increased odds of coronary artery disease and myocardial infarction (odds ratio per 0.5-mg/dL increase in genetically predicted serum calcium levels, 1.25 and 1.24, respectively). Meaning A genetic predisposition to higher serum calcium levels was associated with increased risk of coronary artery disease and myocardial infarction. European ancestry and which were replicated in up to additional individuals (up to individuals). 16 These 7 SNPs were associated with serum calcium levels at genome-wide significance level ([P <5.0] 10 8 )inthe meta-analysis of the discovery and replication cohorts. 16 All the SNPs were in different gene regions and were distributed independently, not in linkage disequilibrium. Among the GWAS, each calcium-associated SNP was evaluated for pleiotropic associations with potential confounders, including major lipids in up to individuals (Global Lipids Genetics Consortium) 17 ; glycemic traits in up to individuals without diabetes (Meta-Analyses of Glucose and Insulin-Related Traits Consortium) 18 ; type 2 diabetes in up to individuals (Diabetics Genetics Replication and Meta-analysis) 19 ; body mass index (BMI) in up to individuals 20 and waist-to-hip ratio adjusted for BMI in up to individuals 21 (Genetic Investigation of Anthropometric Traits); and systolic and diastolic blood pressure in up to individuals (International Consortium for Blood Pressure) 22 (Figure 2). Of the 7 SNPs associated with serum calcium, 1 variant (rs in the GCKR gene region) had pleiotropic associations at the Bonferronicorrected significance threshold ([P <.05]/7 SNPs =.007) with lipids, glycemic traits, type 2 diabetes, and measures of adiposity (etable in the Supplement). To avoid violations of the mendelian randomization assumptions (Figure 1), the pleiotropic SNP was omitted. Thus, 6 SNPs associated with serum calcium were used as instrumental variables in the mendelian randomization analyses. Summary statistics for the associations of the 6 remaining calcium-associated SNPs with the prespecified primary outcomes of CAD and myocardial infarction were extracted from the Coronary Artery Disease Genome-Wide Replication and Meta-analysis plus the Coronary Artery Disease Genetics (CardiogramplusC4D) consortium s 1000 genomes-based genome-wide association meta-analysis of 48 studies. 23 Case status was determined using a broad definition of CAD, including myocardial infarction (approximately 70% of the total number of cases), acute coronary syndrome, chronic stable angina, or coronary artery stenosis greater than 50% (Table 1) JAMA July 25, 2017 Volume 318, Number 4 (Reprinted) jama.com

3 Genetic Variants in Serum Calcium and Coronary Artery Disease Original Investigation Research Figure 1. Schematic Diagram of the Mendelian Randomization Assumptions Underpinning a Mendelian Randomization Analysis of the Association Between Serum Calcium Levels and Coronary Artery Disease Assumption 2 Genetic variants are not associated with either known or unknown confounders Assumption 1 Genetic variants directly affect the risk factor Confounders Instrumental variables Calcium-associated SNPs Risk factor Serum calcium Outcome Coronary artery disease Assumption 3 Genetic variants affect the outcome through only the risk factor and not through other pathways SNPs indicate single-nucleotide polymorphisms. The dashed lines represent potential causal associations between variables that would represent violations of the mendelian randomization assumptions. For a formal treatment of the assumptions, see Greenland. 14 Figure 2. Data Sources and Analysis Plan Using Mendelian Randomization Assessment of pleiotropic associations with potential confounders a GLGC 17 Major lipids Genetic variants 7 SNPs related to serum calcium level at genome-wide significance level ([P < 5.0] x 10-8 ) identified in a genome-wide association study meta-analysis 16 (N= individuals) MAGIC 18 Fasting glucose Fasting insulin DIAGRAM 19 Type 2 diabetes GIANT 20,21 BMI Waist-to-hip ratio Pleiotropic and nonpleiotropic variants 1 SNP with pleiotropic associations excluded b 6 SNPs without known pleitropic associations with cardiometabolic risk factors Mendelian randomization analysis CardiogramplusC4D c CAD cases Noncases ICBP 22 Systolic blood pressure Diastolic blood pressure BMI indicates body mass index; DIAGRAM, Diabetes Genetics Replication and Meta-analysis; GIANT, Genetic Investigation of Anthropometric Traits; GLGC, Global Lipids Genetics Consortium; ICBP, International Consortium of Blood Pressure; MAGIC, Meta-Analyses of Glucose and Insulin-related traits Consortium; SNPs, single-nucleotide polymorphisms. a For sample sizes of each study, see Methods. b Any SNP with pleiotropic effects (ie, associated with more than 1 risk factor) violates the Mendelian randomization assumptions. One SNP (rs in the GCKR gene region) had pleiotropic associations with cardiometabolic risk factors and was excluded, leaving 6 calcium-related SNPs for inclusion in the mendelian randomization analyses. c The estimates for the association of each SNP with coronary artery disease were combined using the inverse-variance weighted method, with summary statistics for coronary artery disease obtained from the CardiogramplusC4D consortium. 23 Statistical Analysis SNPs were matched across the data sources by assigning them to the same effect allele. The association of each SNP with CAD and myocardial infarction was weighted by its association with serum calcium, and estimates were combined using an inverse-variance weighted meta-analysis. 24 Complementary analyses using the weighted median and MR-Egger regression methods were performed. 24 The odds ratios (ORs) of CAD and myocardial infarction were scaled per 0.5-mg/dL increase (about 1 SD) in serum calcium levels. For the calcium-associated SNPs, the summary statistics were based on 44 to all 48 studies included in the CardiogramplusC4D consortium. All statistical tests were 2-sided. The threshold of statistical significance for the analyses of 6 SNPs by Bonferroni correction was P <.008 ([P <.05]/6 SNPs); statistical tests for the mendelian jama.com (Reprinted) JAMA July 25, 2017 Volume 318, Number 4 373

4 Research Original Investigation Genetic Variants in Serum Calcium and Coronary Artery Disease Table 1. Descriptive Information of the 48 Studies Included in the CardiogramplusC4D Consortium s 1000 Genomes-Based Genome-Wide Genome-Wide Association Meta-analysis Source Atherosclerotic Disease, Vascular Function, and Genetic Epidemiology Age, Gene/Environment Susceptibility Reykjavik Atherosclerosis Risk in Communities Beijing Hospital Atherosclerosis Design (Years of Baseline Collection) Country (Ancestry) ( ) ( ) ( ) Cases Noncases With CAD Individuals (% Women) a With MI, % Age, Mean (SD), y (% Women) a Age, Mean (SD) Case Definition United States (white European) 278 (58) (6) 312 (59) 45 (6) MI, angina with 1 angiographic stenosis of >50%, or revascularization procedure (in men aged 18 to 45 y or women aged 18 to 55 y at the time of the event), incident stable exertional angina at an older age, and incident nonfatal MI at an older age Iceland (white European) 397 (NA) 80 NA 2474 (58) b 76 (5) b MI, validated by death certificates, hospital records, and autopsy records United States (white European) 454 (19) (5) 8443 (45) 54 (6) NA (NA) China (Chinese) 505 (15) (9) 1021 (26) 48 (8) Confirmed MI Cardiogenics (NA) Germany, United Kingdom (white European) GeneBank at the Cleveland Clinic ( ) 392 (14) (9) 410 (61) 54 (7) Confirmed MI and acute coronary syndrome with stenosis >50% in 1 major coronary artery United States (white European) 1628 (22) 60 NA 368 (45) 64 (11) b MI, coronary artery bypass graft, percutaneous intervention, or 50% stenosis in 1 epicardial vessel China Atherosclerosis (NA) China (Chinese) 1010 (16) (8) 3998 (53) 53 (8) MI or >70% stenosis in 1 major epicardial vessel or >50% stenosis in the left main coronary artery Corogene ( ) Catheterization Genetics Estonian Genome Center, University of Tartu ( ) ( ) Finland (white European) 2083 (NA) (12) 2048 (36) b 57 (11) MI and CAD (not specified) United States (white European) 1216 (31) (10) 653 (59) 63 (9) 1 epicardial coronary vessel with 50% stenosis Estonia (white European) 658 (50) 20 NA 5841 (51) NA CAD (ICD-10 codes I20-I25), including MI (ICD-10 codes I21 and I22) Family Heart (1992) United States (white European) 334 (NA) 9 NA 3446 (54) b 51 (14) b MI, coronary bypass, or coronary angioplasty, balloon angioplasty, atherectomy, stent, percutaneous transluminal coronary angioplasty, or percutaneous coronary intervention Functional Genomic Diagnostic Tools for Coronary Artery Disease ( ) Lebanon (Lebanese) 1802 (25) (11) 466 (56) 56 (12) MI diagnosed by ECG and high troponin levels, unstable or stable angina, heart failure, or reversible ischemia Framingham Heart (1948) United States (white European) 259 (NA) 6 65 (13) 4202 (NA) 75 (12) Nonfatal MI (diagnosed with documented evidence from ECG or elevated enzymes) or CHD (defined as recognized fatal or nonfatal MI, coronary insufficiency, or the first fatal CHD event Genomics Research in Cardiovascular Disease (NA) Korea (East Asian) 2099 ( ~ 39) 30 52(8) 2690( 56) 53(8) MI, stableangina, or unstable angina (continued) 374 JAMA July 25, 2017 Volume 318, Number 4 (Reprinted) jama.com

5 Genetic Variants in Serum Calcium and Coronary Artery Disease Original Investigation Research Table 1. Descriptive Information of the 48 Studies Included in the CardiogramplusC4D Consortium s 1000 Genomes-Based Genome-Wide Genome-Wide Association Meta-analysis (continued) Source German Myocardial Infarction Family Design (Years of Baseline Collection) Country (Ancestry) Cases Noncases With CAD Individuals (% Women) a With MI, % Age, Mean (SD), y (% Women) a Age, Mean (SD) Case Definition I (NA) Germany (white European) 634 (34) (8) 1608 (51) 63 (10) Included patients who had MI at an early age II (NA) Germany (white European) 1207 (21) (8) 1288 (49) 51 (12) Confirmed MI with an early age (<60 y) of onset and a positive family history for CAD III (KORA) (NA) Germany (white European) 1061 (21) (9) 1467 (52) 58 (10) Nonfatal MI diagnosed by the use of the algorithm of the World Health Organization's Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) project IV (KORA) (NA) Germany (white European) 1089 (36) (10) 1147 (62) 57 (17) MI or CAD defined as 50% stenosis in 1 major coronary vessel and age of onset <65 y in men and <70 y in women Genetics of Diabetes and Audit Research in Tayside and Scotland Medical Research Council and British Heart Foundation Heart Protection Helsinki Sudden Death and the Tampere Coronary Biome Biobank Program at Mt Sinai (NA) Scotland (white European) 877 (NA) NA NA 2187 (NA) NA Nonfatal and fatal MI, unstable angina or coronary revascularization Nested CC ( ) ( ) (2007) (2007) (2007) United Kingdom (white European) 2700 (24) (9) 2758 (73) 50 (15) History of MI, unstable or stable angina, coronary artery bypass grafting, or angioplasty Finland (white European) 206 (0) 46 NA 259 (0) NA Coronary artery stenosis 50, old or acute MI, or sudden cardiac death caused by plaque rupture and thrombosis United States (African Americans) United States (European American) United States (Hispanic American) 361 (67) 36 NA 2778 (71) NA NA 487 (35) 30 NA 1381 (62) NA NA 758 (55) 37 NA 3337 (71) NA NA INTERHEART study (NA) Worldwide (white European) 402 (29) (11) 448 (33) 64 (10) Incident acute MI, presenting to a hospital within 24 h of symptom onset Leipzig Research Center for Civilization Diseases Heart London Life Sciences Prospective Population Ludwigshafen Risk and Cardiovascular Health ( ) Germany (white European) 1535 (25) (11) 772 (50) 64 (11) Luminal reduction of >50% in any vessel (2002-NA) United Kingdom (white European) ( ) 2791 (19) (1) 3757 (14) 52 (10) History of MI, coronary artery revascularization, or angiographically confirmed coronary artery stenosis >50% Germany (white European) 2095 (25) 63 NA 503 (48) 63 (11) a Luminal narrowing (>50% stenosis) in 15 coronary segments according to a classification of the American Heart Association (continued) jama.com (Reprinted) JAMA July 25, 2017 Volume 318, Number 4 375

6 Research Original Investigation Genetic Variants in Serum Calcium and Coronary Artery Disease Table 1. Descriptive Information of the 48 Studies Included in the CardiogramplusC4D Consortium s 1000 Genomes-Based Genome-Wide Genome-Wide Association Meta-analysis (continued) Source Mayo Vascular Diseases Biorepository Medstar cardiac catheterization study Myocardial Infarction Genetics Consortium Ottawa Heart Genetic Design (Years of Baseline Collection) Country (Ancestry) (2009-) ( ) Cases Noncases With CAD Individuals (% Women) a With MI, % Age, Mean (SD), y (% Women) a Age, Mean (SD) Case Definition United States (white European) 745 (NA) NA NA 1389 (NA) NA History of MI, coronary revascularization, angina with a positive stress test result, or >50% stenosis of an epicardial coronary artery on coronary angiography United States (white European) 875 (33) (7) 447 (55) 60 (9) 1 coronary vessel(s) with 50% stenosis (NA) United States (white European) 2905 (25) 100 NA 2998 (27) NA MI diagnosed on the basis of autopsy evidence of fatal MI or a combination of chest pain, ECG evidence of MI, or elevation of 1 cardiac biomarkers A2 (NA) Canada (white European) 947 (25) 64 NA 1008 (51) NA MI, coronary artery bypass graft, percutaneous intervention or a stenosis of 50% in 1 epicardial vessel B2 (NA) Canada (white European) 1294 (22) 56 NA 1529 (50) NA MI, coronary artery bypass graft, percutaneous intervention or a stenosis of 50% in 1 epicardial vessel C2 (NA) Canada (white European) 843 (6) 44 NA 318 (67) NA MI, coronary artery bypass graft, percutaneous intervention or a stenosis of 50% in 1 epicardial vessel PennCath (NA) United States (white European) 933 (24) (8) 468 (52) 62 (10) 1 coronary vessels with 50% stenosis Prospective Investigation of the Vasculature in Uppsala Seniors A subset of FINRISK cohort study Precocious Coronary Artery Disease Pakistan Risk of Myocardial Infarction Pakistan Risk of Myocardial Infarction II Prospective of Pravastatin in the Elderly at Risk (2001-NA) Sweden (white European) 119 (24) (7) 830 (55) 70 (0.2) Fatal or nonfatal MI, stable or unstable angina, coronary revascularization, or coronary artery stenosis ( ) ( ) Finland (white European) 631 (31) 40 NA 334 (43) NA MI, unstable angina, coronary revascularization, or CHD death Germany, Sweden, Italy, United Kingdom (white European) 5719 (29) (8) 6545 (63) NA MI, intervention for coronary revascularization, symptomatic acute coronary syndrome, or chronic stable angina with an age at diagnosis of 65 y (NA) Pakistan (South Asian) 4651 (NA) (11) 4452 (NA) 54 (10) MI within 24 h of hospital presentation; typical ECG changes; and positive troponin I test result (NA) Pakistan (South Asian) 4380 (NA) 100 NA 3929 (NA) NA MI within 24 h of hospital presentation; typical ECG changes; and positive troponin I test result Nested (1998-NA) Rotterdam ( ) Sikh Diabetes and Asian Indian Diabetic Heart Scotland, Ireland, the Netherlands (white European) 2034 (47) (3) 3210 (47) 75 (3) MI and other unspecified CAD cases Netherlands (white European) 506 (NA) 83 NA 5335 (58) 67 (8) b MI and other unspecified CAD cases (NA) India (Indian, Asian, or Punjabi) 836 (30) 80 NA 761 (49) NA MI, nitrate medication use (nitroglycerine), angina pain, or >50% coronary artery stenosis (continued) 376 JAMA July 25, 2017 Volume 318, Number 4 (Reprinted) jama.com

7 Genetic Variants in Serum Calcium and Coronary Artery Disease Original Investigation Research Table 1. Descriptive Information of the 48 Studies Included in the CardiogramplusC4D Consortium s 1000 Genomes-Based Genome-Wide Genome-Wide Association Meta-analysis (continued) Cases Noncases Case Definition (% Women) a Age, Mean (SD) With CAD Individuals (% Women) a With MI, % Age, Mean (SD), y Design (Years of Baseline Collection) Country (Ancestry) Source Greece (white European) 426 (21) 60 ~ 59 (14) 594 (56) ~ 60 (14) Acute MI or unstable angina corresponding to class III of the Braunwald classification ( ) Hellenic of Interactions between SNPs and Eating in Atherosclerosis Susceptibility Sweden (white European) 814 (29) 71 NA 5999 (56) 65 (8) b Fatal or nonfatal MI, stable or unstable angina, coronary revascularization, or coronary artery stenosis TwinGene ( ) (NA) Sweden (white European) 322 (0) 84 NA 857 (0) 71 (1) b Fatal or nonfatal MI, stable or unstable angina, coronary revascularization, or coronary artery stenosis Uppsala Longitudinal of Adult Men United States (white European) 1007 (100) 38 NA (100) 55 (7) b NA ( ) Women's Genome Health 1926 (21) (8) 2938 (51) 50 (8) History of MI or coronary revascularization United Kingdom (white European) (2005-NA) Wellcome Trust Case Control Consortium a The number of cases and noncases in each study do not sum to the number of individuals included in the analysis because a few individuals were removed after quality control criteria were established. b Based on the whole cohort at baseline. Abbreviations:CAD,coronaryarterydisease;CHD,coronaryheartdisease;ECG,electrocardiogram/electrocardiography; ICD-10, International Classification of Diseases, 10th Revision; MI, myocardial infarction; NA, not available. randomization analyses of CAD and myocardial infarction were considered statistically significant at P <.025 ([P <.05]/2 outcome measures). All analyses were conducted in Stata (StataCorp), version 14.2, and R (R Foundation), version Results The analytic sample included up to CAD cases (approximately 70% with myocardial infarction) and noncases from 48 cohort and case-control studies. The majority of participants were of European (77%), South Asian (13%), and East Asian (6%) ancestry (Table 1). The 6 SNPs related to serum calcium levels and without pleiotropic associations with potential confounders were estimated to explain about 0.8% of the variation in serum calcium levels. None of the individual 6 SNPs was associated with CAD at Bonferroni corrected significance level (P <.008) (Table 2). In the overall inverse-variance weighted metaanalysis of the 6 SNPs, the OR of CAD per 0.5-mg/dL increase (about 1 SD) in genetically predicted serum calcium was 1.25 (95% CI, ; P =.003) (Figure 3). In a sensitivity analysis excluding the SNP in the CASR gene, which provided the most weight to the overall estimate, the OR of CAD was 1.25 (95% CI, ). An analysis of patients with only myocardial infarction as the outcome (about 70% of all study cases) yielded similar results (OR, 1.24 [95% CI, ]; P =.009) (efigure in the Supplement). The association between genetically predicted serum calcium levels and CAD was consistent in complementary analyses using the weighted median method (OR, 1.25 [95% CI, ]) and MR-Egger regression, although with a wider CI (OR, 1.26 [95% CI, ]). There was no evidence of pleiotropy (MR-Egger intercept, ; P =.96), or heterogeneity between the mendelian randomization estimates from different SNPs (I 2 = 0%, P =.78for heterogeneity). Discussion This mendelian randomization study showed that a genetic predisposition to higher serum calcium levels was associated with increased risk of CAD and myocardial infarction. The OR per 0.5-mg/dL increase (about 1 SD) in serum calcium levels was 1.25 for CAD and 1.24 for myocardial infarction. The risk increase is similar or weaker in magnitude to previously reported genetic associations (per 1-SD increase) with triglyceride levels (OR, 1.28), 25 low-density lipoprotein cholesterol levels (OR, 1.68), 25 systolic and diastolic blood pressure (OR, 1.49), 26 and body mass index (OR, 1.40). 27 The finding from this study corroborates results from several observational studies showing a positive association of serum calcium levels with risk of cardiovascular disease. 1,2 A meta-analysis of 8 observational studies found a hazard ratio of cardiovascular disease of 1.08 (95% CI, ) per 1-SD increment of serum calcium levels and a corresponding OR of 1.22 (95% CI, ) in 2 studies that reported ORs. 1 jama.com (Reprinted) JAMA July 25, 2017 Volume 318, Number 4 377

8 Research Original Investigation Genetic Variants in Serum Calcium and Coronary Artery Disease Table 2. Characteristics of the Calcium-Associated Genetic Variants SNP Nearby Gene Chromosome Effect Allele a Frequency b Effect Allele Calcium Results CAD Results OR β (mg/dl) c P Value c Variance, % d (95% CI) e P Value e rs CASR 3 T ( ) rs CYP24A1 20 G ( ) rs DGKD 2 C ( ) rs CARS 11 G ( ) rs DGKH/KIAA G ( ) rs GATA3 10 T ( ) Abbreviations: CAD, coronary artery disease; OR, odds ratio; SNP, single-nucleotide polymorphism. a Calcium-raising allele. b Frequency of the calcium-raising allele, expressed as a proportion, in the CardiogramplusC4D consortium. 23 c Summary statistics per effect allele for serum calcium levels obtained from a genome-wide association meta-analysis of about individuals of European ancestry. 16 As an example, for the genetic variant in CASR, serum calcium levels increase by mg/dl per additional T allele. d Proportion of variance in serum calcium explained by each SNP. Calculated as r 2 = 2 minor allele frequency (1 minor allele frequency) (β/sd), 2 where 1 SD equals 0.5 mg/dl. e Effect size estimate (β coefficient, measured as log OR of CAD per additional calcium-raising allele, and standard error) and P value for each SNP on CAD were obtained from the CardiogramplusC4D consortium (a 1000 genomes-based genome-wide association meta-analysis of 48 studies) comprising a total of CAD cases and noncases Figure 3. Mendelian Randomization Estimates of the Association Between Genetically Predicted Serum Calcium Levels and Coronary Artery Disease SNP Nearby Gene Effect Allele/ Noneffect Allele Studies OR (95% CI) of CAD per 0.5-mg/dL Increase in Genetically Predicted Serum Calcium Level rs CASR T/G ( ) rs CYP24A1 G/A ( ) rs DGKD C/G ( ) rs CARS G/A ( ) rs DGKH/KIAA0564 G/A ( ) rs GATA3 T/C ( ) Overall 1.25 ( ) OR (95% CI) per 0.5-mg/dL Increase in 4.0 Genetically Predicted Serum Calcium Level P Value OR indicates odds ratio; SNP, single-nucleotide polymorphisms. Data markers indicate the OR for the association of each calcium-associated SNP with coronary artery disease. Size of the data marker is inversely proportional to variance of the estimate. Error bars indicate 95% CIs. Data from randomized clinical trials indicate that calcium supplementation leads to hypercalcemia 3,4 and increased transition of soluble calcium-related protein particles to insoluble calciprotein particles reflecting higher concentrations of activators of calcification present in serum, 28 as well as an increased risk of myocardial infarction. 5 Based on results from interventions, there is a peak in ionized and total serum calcium levels 4 hours after ingestion of 1000-mg supplemental calcium and the increase in total serum calcium corresponds to about 1 SD. 3 A similar increase in serum calcium from baseline over 6 hours is observed following the ingestion of a 500-mg calcium supplement, whereas the increase in serum calcium after a corresponding calcium dose by a dairy product intake is less pronounced. 29 In a meta-analysis of 9 randomized clinical trials, calcium supplementation with or without vitamin D increased the risk of myocardial infarction by 24%, 5 but the result is disputed Findings from observational studies further show that calcium supplement use is associated with increased risk of incident coronary artery calcification, 30 incident myocardial infarction, 31 and coronary heart disease mortality. 32 Possible mechanisms whereby elevated serum calcium levels may increase the risk of CAD include effects on vascular calcification, vascular cells, blood coagulation, and altered gene expression induced by effects on arterial wall calcium-sensing receptor. 10 The potential mechanisms underlying the association need to be more thoroughly evaluated. Strengths of this mendelian randomization analysis include the large sample size and the use of multiple uncorre- 378 JAMA July 25, 2017 Volume 318, Number 4 (Reprinted) jama.com

9 Genetic Variants in Serum Calcium and Coronary Artery Disease Original Investigation Research lated SNPs associated with serum calcium levels, which increases the precision of the estimate. Limitations This study has several limitations. First, the genetic variant in the CASR gene provided more weight, explained by the stronger relation between this SNP and serum calcium, than the other variants to the overall estimate of the genetic association between serum calcium levels and CAD. However, 4 of the other 5 variants associated with serum calcium had positive estimates for association with CAD, and 3 variants had higher ORs for association with CAD per 0.5 mg/dl increase in serum calcium compared with the genetic variant in the CASR gene. Moreover, the overall estimate was identical although with lower precision after omitting the variant in CASR. CASR encodes the calcium-sensing receptor, which plays a key role in calcium homeostasis. Second, there was partial overlap between studies included in the GWAS meta-analysis of calcium (N = ) and the CardiogramplusC4D consortium (N = ). This could result in model overfitting if the SNP-calcium associations were estimated in studies that were included in the CardiogramplusC4D consortium. Of the 28 studies included in the GWAS meta-analysis of calcium, 9 were also included in CardiogramplusC4D. If all the individuals in each of these studies appeared in both meta-analyses, then there would be an overlap of of the individuals in the calcium GWAS meta-analysis. This could potentially lead to a small bias in mendelian randomization estimates. However, if genetic associations with serum calcium levels were estimated in noncases only (as is usual for continuous phenotypes such as serum calcium levels), then this sample overlap would not lead to bias or type 1 error inflation. 33 Third, the study lacked complete information on sex and age, and that a potential nonlinear association between serum calcium levels and CAD could not be evaluated. Fourth, a replication data set with a similar large number of CAD cases was not available. The reliability of the findings from a mendelian randomization study depends on 3 key assumptions (Figure 1), which could be violated by population stratification, canalization, pleiotropy, and linkage disequilibrium. It cannot be completely ruled out that population stratification may have had some influence on the results because the CardiogramplusC4D consortium included individuals of different ancestry with potentially different allele frequencies. However, analyses for the CardiogramplusC4D consortium were conducted separately in each study and then combined, and adjustment was made for genetic principal components, mitigating the potential effect of population stratification. Furthermore, the vast majority of participants in CardiogramplusC4D were of European descent and the effect allele frequencies of the 6 calcium-associated SNPs were very similar in CardiogramplusC4D and the GWAS meta-analysis of calcium. The SNP in the CASR gene has been consistently associated with serum calcium in populations of different ancestry, including Europeans, Indian Asians, and Japanese. 16,34 The other 5 SNPs were robustly associated with serum calcium in a GWAS meta-analysis of about individuals. 16 Whether canalization, which is defined as compensatory feedback mechanisms, may have affected the results could not be directly tested. Because canalization assumes that there are other mechanisms that mitigate the genetic effect, such feedback mechanisms would bias the results toward the null and cannot explain the observed association. Several approaches were undertaken to assess and adjust for potential confounding or pleiotropic effects. First, each SNP associated with serum calcium was assessed for associations with known cardiometabolic risk factors for CAD, and 1 SNP with pleiotropic associations was excluded. In addition, sensitivity analyses using the weighted median and MR-Egger regression approaches to explore and adjust for pleiotropy were conducted. The results were consistent in these analyses, indicating that confounding is unlikely to explain the observed association. Linkage disequilibrium with directly causal variants (violating the third assumption) was likely avoided owing to the use of multiple SNPs of which most were positively associated with CAD. Conclusions A genetic predisposition to higher serum calcium levels was associated with increased risk of CAD and myocardial infarction. Whether the risk of CAD associated with lifelong genetic exposure to increased serum calcium levels can be translated to a risk associated with short-term to medium-term calcium supplementation is unknown. ARTICLE INFORMATION Accepted for Publication: June 23, Author Contributions: Dr Larsson had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: Larsson. Acquisition, analysis, or interpretation of data: All authors. Drafting of the manuscript: Larsson, Burgess. Critical revision of the manuscript for important intellectual content: Larsson, Michaëlsson. Statistical analysis: Larsson, Burgess. Obtained funding: Larsson. Administrative, technical, or material support: Larsson. Supervision: Larsson, Michaëlsson. Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported. Funding/Support: This work was supported by a Junior Researcher Award grant from the Strategic Research Area in Epidemiology at Karolinska Institutet (Dr Larsson). Role of the Funder/Sponsor: The funding source had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Additional Contributions: Data on genetic associations with coronary artery disease and myocardial infarction have been contributed by CardiogramplusC4D investigators and have been downloaded from REFERENCES 1. Reid IR, Gamble GD, Bolland MJ. Circulating calcium concentrations, vascular disease and mortality: a systematic review. J Intern Med. 2016; 279(6): jama.com (Reprinted) JAMA July 25, 2017 Volume 318, Number 4 379

10 Research Original Investigation Genetic Variants in Serum Calcium and Coronary Artery Disease 2. Rohrmann S, Garmo H, Malmström H, et al. Association between serum calcium concentration and risk of incident and fatal cardiovascular disease in the prospective AMORIS study. Atherosclerosis. 2016;251: Bristow SM, Gamble GD, Stewart A, et al. Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women. Br J Nutr. 2014;112(10): Barry EL, Mott LA, Melamed ML, et al. Calcium supplementation increases blood creatinine concentration in a randomized controlled trial. PLoS One. 2014;9(10):e Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women s Health Initiative limited access dataset and meta-analysis. BMJ. 2011;342:d Van Hemelrijck M, Michaelsson K, Linseisen J, Rohrmann S. Calcium intake and serum concentration in relation to risk of cardiovascular death in NHANES III. PLoS One. 2013;8(4):e Mangano KM, Walsh SJ, Insogna KL, Kenny AM, Kerstetter JE. Calcium intake in the United States from dietary and supplemental sources across adult age groups: new estimates from the National Health and Nutrition Examination Survey J Am Diet Assoc. 2011;111(5): An R, Chiu CY, Andrade F. Nutrient intake and use of dietary supplements among US adults with disabilities. Disabil Health J. 2015;8(2): Dickinson A, MacKay D. Health habits and other characteristics of dietary supplement users: a review. Nutr J. 2014;13: Reid IR, Bristow SM, Bolland MJ. Cardiovascular complications of calcium supplements. J Cell Biochem. 2015;116(4): Margolis KL, Manson JE. Calcium supplements and cardiovascular disease risk: what do clinicians and patients need to know? Ann Intern Med. 2016; 165(12): Bauer DC. The calcium supplement controversy: now what? J Bone Miner Res. 2014;29 (3): Burgess S, Thompson SG. Mendelian randomization: methods for using genetic variants in causal estimation. London, UK: Chapman & Hall; Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol. 2000;29(4): Burgess S, Scott RA, Timpson NJ, Davey Smith G, Thompson SG; EPIC- InterAct Consortium. Using published data in mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol. 2015;30(7): O Seaghdha CM, Wu H, Yang Q, et al; SUNLIGHT Consortium; GEFOS Consortium. Meta-analysis of genome-wide association studies identifies six new Loci for serum calcium concentrations. PLoS Genet. 2013;9(9):e Willer CJ, Schmidt EM, Sengupta S, et al; Global Lipids Genetics Consortium. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45(11): Dupuis J, Langenberg C, Prokopenko I, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010;42(2): Mahajan A, Go MJ, Zhang W, et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet. 2014;46 (3): Locke AE, Kahali B, Berndt SI, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518(7538): Shungin D, Winkler TW, Croteau-Chonka DC, et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature. 2015;518 (7538): Ehret GB, Munroe PB, Rice KM, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478 (7367): Nikpay M, Goel A, Won HH, et al; CARDIoGRAMplusC4D Consortium. A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet. 2015;47(10): Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants. Epidemiology. 2017; 28(1): White J, Swerdlow DI, Preiss D, et al. Association of lipid fractions with risks for coronary artery disease and diabetes. JAMA Cardiol. 2016;1 (6): van Iperen EP, Sivapalaratnam S, Holmes MV, Hovingh GK, Zwinderman AH, Asselbergs FW. Genetic analysis of emerging risk factors in coronary artery disease. Atherosclerosis. 2016;254: Hägg S, Fall T, Ploner A, et al; European Network for Genetic and Genomic Epidemiology Consortium. Adiposity as a cause of cardiovascular disease: a mendelian randomization study. Int J Epidemiol. 2015;44(2): Bristow SM, Gamble GD, Pasch A, et al. Acute and 3-month effects of calcium carbonate on the calcification propensity of serum and regulators of vascular calcification: secondary analysis of a randomized controlled trial. Osteoporos Int. 2016; 27(3): Bristow SM, Gamble GD, Stewart A, Kalluru R, Horne AM, Reid IR. Acute effects of calcium citrate with or without a meal, calcium-fortified juice and a dairy product meal on serum calcium and phosphate: a randomised cross-over trial. Br J Nutr. 2015;113(10): Anderson JJ, Kruszka B, Delaney JA, et al. Calcium intake from diet and supplements and the risk of coronary artery calcification and its progression among older adults: 10-year follow-up of the Multi-Ethnic of Atherosclerosis (MESA). J Am Heart Assoc. 2016;5(10):e Li K, Kaaks R, Linseisen J, Rohrmann S. Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg). Heart. 2012;98(12): Xiao Q, Murphy RA, Houston DK, Harris TB, Chow WH, Park Y. Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med. 2013;173(8): Burgess S, Davies NM, Thompson SG. Bias due to participant overlap in two-sample mendelian randomization. Genet Epidemiol. 2016;40(7): Kapur K, Johnson T, Beckmann ND, et al. Genome-wide meta-analysis for serum calcium identifies significantly associated SNPs near the calcium-sensing receptor (CASR) gene. PLoS Genet. 2010;6(7):e JAMA July 25, 2017 Volume 318, Number 4 (Reprinted) jama.com

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Lotta LA, Stewart ID, Sharp SJ, et al. Association of genetically enhanced lipoprotein lipase mediated lipolysis and low-density lipoprotein cholesterol lowering alleles with

More information

Investigating causality in the association between 25(OH)D and schizophrenia

Investigating causality in the association between 25(OH)D and schizophrenia Investigating causality in the association between 25(OH)D and schizophrenia Amy E. Taylor PhD 1,2,3, Stephen Burgess PhD 1,4, Jennifer J. Ware PhD 1,2,5, Suzanne H. Gage PhD 1,2,3, SUNLIGHT consortium,

More information

During the hyperinsulinemic-euglycemic clamp [1], a priming dose of human insulin (Novolin,

During the hyperinsulinemic-euglycemic clamp [1], a priming dose of human insulin (Novolin, ESM Methods Hyperinsulinemic-euglycemic clamp procedure During the hyperinsulinemic-euglycemic clamp [1], a priming dose of human insulin (Novolin, Clayton, NC) was followed by a constant rate (60 mu m

More information

Advanced IPD meta-analysis methods for observational studies

Advanced IPD meta-analysis methods for observational studies Advanced IPD meta-analysis methods for observational studies Simon Thompson University of Cambridge, UK Part 4 IBC Victoria, July 2016 1 Outline of talk Usual measures of association (e.g. hazard ratios)

More information

Mendelian randomization does not support serum calcium in prostate cancer risk

Mendelian randomization does not support serum calcium in prostate cancer risk Cancer Causes & Control (2018) 29:1073 1080 https://doi.org/10.1007/s10552-018-1081-5 ORIGINAL PAPER Mendelian randomization does not support serum calcium in prostate cancer risk James Yarmolinsky 1,2

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Ference BA, Robinson JG, Brook RD, et al. Variation in PCSK9

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Hartwig FP, Borges MC, Lessa Horta B, Bowden J, Davey Smith G. Inflammatory biomarkers and risk of schizophrenia: a 2-sample mendelian randomization study. JAMA Psychiatry.

More information

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD

More information

An instrumental variable in an observational study behaves

An instrumental variable in an observational study behaves Review Article Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants Stephen Burgess, a Jack Bowden, b Tove Fall, c Erik Ingelsson, c and

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Lotta LA, Sharp SJ, Burgess S, et al. Association between low-density lipoprotein cholesterol lowering genetic variants and risk of type 2 diabetes: a meta-analysis. JAMA.

More information

Mendelian Randomization

Mendelian Randomization Mendelian Randomization Drawback with observational studies Risk factor X Y Outcome Risk factor X? Y Outcome C (Unobserved) Confounders The power of genetics Intermediate phenotype (risk factor) Genetic

More information

SUPPLEMENTAL MATERIAL

SUPPLEMENTAL MATERIAL SUPPLEMENTAL MATERIAL A Meta-analysis of LDL-C, non-hdl-c, and apob as markers of cardiovascular risk. Slide # Contents 2 Table A1. List of candidate reports 8 Table A2. List of covariates/model adjustments

More information

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors Lecture 8 Cardiovascular Health 1 Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors 1 Human Health: What s Killing Us? Health in America Health is the U.S Average life

More information

Supplementary Figures

Supplementary Figures Supplementary Figures Supplementary Fig 1. Comparison of sub-samples on the first two principal components of genetic variation. TheBritishsampleisplottedwithredpoints.The sub-samples of the diverse sample

More information

Statistical Fact Sheet Populations

Statistical Fact Sheet Populations Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total

More information

Cardiovascular Complications of Diabetes

Cardiovascular Complications of Diabetes VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary

More information

A Naturally Randomized Trial Comparing the Effect of Genetic Variants that Mimic CETP Inhibitors and Statins on the Risk of Cardiovascular Disease.

A Naturally Randomized Trial Comparing the Effect of Genetic Variants that Mimic CETP Inhibitors and Statins on the Risk of Cardiovascular Disease. A Naturally Randomized Trial Comparing the Effect of Genetic Variants that Mimic CETP Inhibitors and Statins on the Risk of Cardiovascular Disease. Brian A. Ference MD, MPhil, MSc, John J. P. Kastelein

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Lyall DM, Celis-Morales C, Ward J, et al. Association of body mass index with cardiometabolic disease in the UK Biobank: a mendelian randomization study. JAMA Cardiol. Published

More information

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor Lecture 9 Cardiovascular Health 1 Lecture 9 1. Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor 1 The Heart Muscular Pump The Heart Receives blood low pressure then increases the pressure

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Åsvold BO, Vatten LJ, Bjøro T, et al; Thyroid Studies Collaboration. Thyroid function within the normal range and risk of coronary heart disease: an individual participant

More information

Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies 1

Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies 1 AJCN. First published ahead of print March 9, 2016 as doi: 10.3945/ajcn.115.118216. Statistical Commentary Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization

More information

Cardiovascular Diseases and Diabetes

Cardiovascular Diseases and Diabetes Cardiovascular Diseases and Diabetes LEARNING OBJECTIVES Ø Identify the components of the cardiovascular system and the various types of cardiovascular disease Ø Discuss ways of promoting cardiovascular

More information

ARIC Manuscript Proposal #2426. PC Reviewed: 9/9/14 Status: A Priority: 2 SC Reviewed: Status: Priority:

ARIC Manuscript Proposal #2426. PC Reviewed: 9/9/14 Status: A Priority: 2 SC Reviewed: Status: Priority: ARIC Manuscript Proposal #2426 PC Reviewed: 9/9/14 Status: A Priority: 2 SC Reviewed: Status: Priority: 1a. Full Title: Statin drug-gene interactions and MI b. Abbreviated Title: CHARGE statin-gene GWAS

More information

A Mendelian Randomized Controlled Trial of Long Term Reduction in Low-Density Lipoprotein Cholesterol Beginning Early in Life

A Mendelian Randomized Controlled Trial of Long Term Reduction in Low-Density Lipoprotein Cholesterol Beginning Early in Life A Mendelian Randomized Controlled Trial of Long Term Reduction in Low-Density Lipoprotein Cholesterol Beginning Early in Life Brian A. Ference, M.D., M.Phil., M.Sc. ACC.12 Chicago 26 March 2012 Disclosures

More information

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease Gjin Ndrepepa, Tomohisa Tada, Massimiliano Fusaro, Lamin King, Martin Hadamitzky,

More information

Association between the CYP11B2 gene 344T>C polymorphism and coronary artery disease: a meta-analysis

Association between the CYP11B2 gene 344T>C polymorphism and coronary artery disease: a meta-analysis Association between the CYP11B2 gene 344T>C polymorphism and coronary artery disease: a meta-analysis Y. Liu, H.L. Liu, W. Han, S.J. Yu and J. Zhang Department of Cardiology, The General Hospital of the

More information

Value and challenges of combining large cohorts

Value and challenges of combining large cohorts Value and challenges of combining large cohorts Rory Collins UK Biobank Principal Investigator BHF Professor of Medicine & Epidemiology Nuffield Department of Population Health Richard Doll Building University

More information

Intermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis

Intermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis Intermediate Methods in Epidemiology 2008 Exercise No. 4 - Passive smoking and atherosclerosis The purpose of this exercise is to allow students to recapitulate issues discussed throughout the course which

More information

Guidelines on cardiovascular risk assessment and management

Guidelines on cardiovascular risk assessment and management European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine

More information

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Hyeon-Cheol Gwon Cardiac and Vascular Center Samsung Medical Center Sungkyunkwan University School of Medicine Dr. Hyeon-Cheol

More information

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,

More information

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply. WHI Form - Report of Cardiovascular Outcome Ver. 6. COMMENTS To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: OMB# 095-044 Exp: 4/06 -Affix label here- Clinical Center/ID:

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Leibowitz M, Karpati T, Cohen-Stavi CJ, et al. Association between achieved low-density lipoprotein levels and major adverse cardiac events in patients with stable ischemic

More information

APPENDIX F: CASE REPORT FORM

APPENDIX F: CASE REPORT FORM APPENDIX F: CASE REPORT FORM Instruction: Complete this form to notify all ACS admissions at your centre to National Cardiovascular Disease Registry. Where check boxes are provided, check ( ) one or more

More information

STABILITY Stabilization of Atherosclerotic plaque By Initiation of darapladib TherapY. Harvey D White on behalf of The STABILITY Investigators

STABILITY Stabilization of Atherosclerotic plaque By Initiation of darapladib TherapY. Harvey D White on behalf of The STABILITY Investigators STABILITY Stabilization of Atherosclerotic plaque By Initiation of darapladib TherapY Harvey D White on behalf of The STABILITY Investigators Lipoprotein- associated Phospholipase A 2 (Lp-PLA 2 ) activity:

More information

University of Bristol - Explore Bristol Research. Peer reviewed version. Link to published version (if available): /j.exger

University of Bristol - Explore Bristol Research. Peer reviewed version. Link to published version (if available): /j.exger Kunutsor, S. K. (2015). Serum total bilirubin levels and coronary heart disease - Causal association or epiphenomenon? Experimental Gerontology, 72, 63-6. DOI: 10.1016/j.exger.2015.09.014 Peer reviewed

More information

JAMA. 2011;305(24): Nora A. Kalagi, MSc

JAMA. 2011;305(24): Nora A. Kalagi, MSc JAMA. 2011;305(24):2556-2564 By Nora A. Kalagi, MSc Cardiovascular disease (CVD) is the number one cause of mortality and morbidity world wide Reducing high blood cholesterol which is a risk factor for

More information

A loss-of-function variant in CETP and risk of CVD in Chinese adults

A loss-of-function variant in CETP and risk of CVD in Chinese adults A loss-of-function variant in CETP and risk of CVD in Chinese adults Professor Zhengming CHEN Nuffield Dept. of Population Health University of Oxford, UK On behalf of the CKB collaborative group (www.ckbiobank.org)

More information

Identification of subjects at high risk for cardiovascular disease

Identification of subjects at high risk for cardiovascular disease Master Class in Preventive Cardiology Focus on Diabetes and Cardiovascular Disease Geneva April 14 2011 Identification of subjects at high risk for cardiovascular disease Lars Rydén Karolinska Institutet

More information

Results of the GLAGOV Trial

Results of the GLAGOV Trial Results of the GLAGOV Trial Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound Steven E. Nissen MD Stephen J. Nicholls MBBS PhD Consulting: Many companies

More information

The Framingham Coronary Heart Disease Risk Score

The Framingham Coronary Heart Disease Risk Score Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Although

More information

9/18/2017 DISCLOSURES. Consultant: RubiconMD. Research: Amgen, NHLBI OUTLINE OBJECTIVES. Review current CV risk assessment tools.

9/18/2017 DISCLOSURES. Consultant: RubiconMD. Research: Amgen, NHLBI OUTLINE OBJECTIVES. Review current CV risk assessment tools. UW MEDICINE UW MEDICINE UCSF ASIAN TITLE HEALTH OR EVENT SYMPOSIUM 2017 DISCLOSURES Consultant: RubiconMD ESTIMATING CV RISK IN ASIAN AMERICANS AND PREVENTION OF CVD Research: Amgen, NHLBI EUGENE YANG,

More information

Association between interleukin-17a polymorphism and coronary artery disease susceptibility in the Chinese Han population

Association between interleukin-17a polymorphism and coronary artery disease susceptibility in the Chinese Han population Association between interleukin-17a polymorphism and coronary artery disease susceptibility in the Chinese Han population G.B. Su, X.L. Guo, X.C. Liu, Q.T. Cui and C.Y. Zhou Department of Cardiothoracic

More information

GSK Medicine: Study Number: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives:

GSK Medicine: Study Number: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

Clinical Trial Synopsis TL-OPI-516, NCT#

Clinical Trial Synopsis TL-OPI-516, NCT# Clinical Trial Synopsis, NCT#00225277 Title of Study: A Double-Blind, Randomized, Comparator-Controlled Study in Subjects With Type 2 Diabetes Mellitus Comparing the Effects of Pioglitazone HCl Versus

More information

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC Am J Cardiol (2004);94:729-32 Relation of degree of physical activity to coronary artery calcium score in asymptomatic individuals with multiple metabolic risk factors M. Y. Desai, et al. Ciccarone Preventive

More information

Antihypertensive Trial Design ALLHAT

Antihypertensive Trial Design ALLHAT 1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes

More information

Evaluation of the causal effects between subjective wellbeing and cardiometabolic health: mendelian randomisation study

Evaluation of the causal effects between subjective wellbeing and cardiometabolic health: mendelian randomisation study 1 School of Experimental Psychology, University of Bristol, Bristol BS8 1TU, UK 2 Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK 3 MRC Integrative

More information

Inflammation and and Heart Heart Disease in Women Inflammation and Heart Disease

Inflammation and and Heart Heart Disease in Women Inflammation and Heart Disease Inflammation and Heart Disease in Women Inflammation and Heart Disease What is the link between een inflammation and atherosclerotic disease? What is the role of biomarkers in predicting cardiovascular

More information

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS Table of Contents List of authors pag 2 Supplemental figure I pag 3 Supplemental figure II pag 4 Supplemental

More information

Potential recommendations for CT coronary angiography in athletes

Potential recommendations for CT coronary angiography in athletes Potential recommendations for CT coronary angiography in athletes B.K. Velthuis Dept. of Radiology UMC Utrecht, the Netherlands EuroPRevent 15 April 2011 Declaration of interest Philips Medical Systems

More information

FTO Polymorphisms Are Associated with Obesity But Not with Diabetes in East Asian Populations: A Meta analysis

FTO Polymorphisms Are Associated with Obesity But Not with Diabetes in East Asian Populations: A Meta analysis BIOMEDICAL AND ENVIRONMENTAL SCIENCES 22, 449 457 (2009) www.besjournal.com FTO Polymorphisms Are Associated with Obesity But Not with Diabetes in East Asian Populations: A Meta analysis BO XI #, + AND

More information

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Sao Paulo Medical School Sao Paolo, Brazil Subclinical atherosclerosis in CVD risk: Stratification & management Prof.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines

More information

Effects of environment and genetic interactions on chronic metabolic diseases

Effects of environment and genetic interactions on chronic metabolic diseases 22 1 2010 1 Chinese Bulletin of Life Sciences Vol. 22, No. 1 Jan., 2010 1004-0374(2010)01-0001-06 ( 200031) 2 2 20 2 2 2 R151; R589; R587.1; R363.16 A Effects of environment and genetic interactions on

More information

Cost-effectiveness of pravastatin for primary prevention of coronary artery disease in Japan Nagata-Kobayashi S, Shimbo T, Matsui K, Fukui T

Cost-effectiveness of pravastatin for primary prevention of coronary artery disease in Japan Nagata-Kobayashi S, Shimbo T, Matsui K, Fukui T Cost-effectiveness of pravastatin for primary prevention of coronary artery disease in Japan Nagata-Kobayashi S, Shimbo T, Matsui K, Fukui T Record Status This is a critical abstract of an economic evaluation

More information

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention

More information

Evolving Challenges in the Evaluation and Treatment of Lower Extremity PAD -- The Peripheral Academic Research Consortium (PARC)

Evolving Challenges in the Evaluation and Treatment of Lower Extremity PAD -- The Peripheral Academic Research Consortium (PARC) Evolving Challenges in the Evaluation and Treatment of Lower Extremity PAD -- The Peripheral Academic Research Consortium (PARC) W. Schuyler Jones, MD FACC Director, Adult Cardiac Catheterization Laboratory

More information

Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center

Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center Aging Research Volume 2013, Article ID 471026, 4 pages http://dx.doi.org/10.1155/2013/471026 Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at

More information

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20. Journal of the American College of Cardiology Vol. 35, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00546-5 CLINICAL

More information

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study Panel Discussion: Literature that Should Have an Impact on our Practice: The Study Kaiser COAST 11 th Annual Conference Maui, August 2009 Robert Blumberg, MD, FACC Ralph Brindis, MD, MPH, FACC Primary

More information

FTO gene variants are strongly associated with type 2 diabetes in South Asian Indians

FTO gene variants are strongly associated with type 2 diabetes in South Asian Indians Diabetologia (2009) 52:247 252 DOI 10.1007/s00125-008-1186-6 SHORT COMMUNICATION FTO gene variants are strongly associated with type 2 diabetes in South Asian Indians C. S. Yajnik & C. S. Janipalli & S.

More information

Ischaemic heart disease. IInd Chair and Clinic of Cardiology

Ischaemic heart disease. IInd Chair and Clinic of Cardiology Ischaemic heart disease IInd Chair and Clinic of Cardiology Definition Syndrome due to chronic insufficient oxygen supply to myocardial cells Nomenclature: ischaemic heart disease (IHD), coronary artery

More information

The TNT Trial Is It Time to Shift Our Goals in Clinical

The TNT Trial Is It Time to Shift Our Goals in Clinical The TNT Trial Is It Time to Shift Our Goals in Clinical Angioplasty Summit Luncheon Symposium Korea Assoc Prof David Colquhoun 29 April 2005 University of Queensland, Wesley Hospital, Brisbane, Australia

More information

EXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT Submitted to UNIVERSITY GRANTS COMMISSION

EXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT Submitted to UNIVERSITY GRANTS COMMISSION 1 A STUDY ON THE EFFECT OF DIET & LIFE STYLE ON THE INCIDENCE OF CORONARY ARTERY DISEASE IN MODERATELY DRINKING EX MILITARY MEN IN PATHANAMTHITTA DISTRICT. EXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT

More information

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases Cardiovascular Disorders Lecture 3 Coronar Artery Diseases By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University Coronary Heart Diseases It is the leading cause of death in

More information

Genetic predisposition to obesity leads to increased risk of type 2 diabetes

Genetic predisposition to obesity leads to increased risk of type 2 diabetes Diabetologia (2011) 54:776 782 DOI 10.1007/s00125-011-2044-5 ARTICLE Genetic predisposition to obesity leads to increased risk of type 2 diabetes S. Li & J. H. Zhao & J. Luan & C. Langenberg & R. N. Luben

More information

Circulation Topic Review

Circulation Topic Review Circulation Topic Review Genetic Epidemiology in Circulation and the Circulation Subspecialty Journals The Editors The following articles are being highlighted as part of Circulation s Topic Review series.

More information

Case Presentation. Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer

Case Presentation. Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer Case Presentation Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer Case Presentation 50 YO man NSTEMI treated with PCI 1 month ago Medical History: Obesity: BMI 32,

More information

Articles. Funding Medical Research Council, National Institute for Health Research, and Wellcome Trust.

Articles. Funding Medical Research Council, National Institute for Health Research, and Wellcome Trust. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1 5 million people Eleni Rapsomaniki, Adam Timmis, Julie George,

More information

8/10/2012. Education level and diabetes risk: The EPIC-InterAct study AIM. Background. Case-cohort design. Int J Epidemiol 2012 (in press)

8/10/2012. Education level and diabetes risk: The EPIC-InterAct study AIM. Background. Case-cohort design. Int J Epidemiol 2012 (in press) Education level and diabetes risk: The EPIC-InterAct study 50 authors from European countries Int J Epidemiol 2012 (in press) Background Type 2 diabetes mellitus (T2DM) is one of the most common chronic

More information

Outline. Introduction GitHub and installation Worked example Stata wishes Discussion. mrrobust: a Stata package for MR-Egger regression type analyses

Outline. Introduction GitHub and installation Worked example Stata wishes Discussion. mrrobust: a Stata package for MR-Egger regression type analyses mrrobust: a Stata package for MR-Egger regression type analyses London Stata User Group Meeting 2017 8 th September 2017 Tom Palmer Wesley Spiller Neil Davies Outline Introduction GitHub and installation

More information

Critical Review Form Therapy Objectives: Methods:

Critical Review Form Therapy Objectives: Methods: Critical Review Form Therapy Clinical Trial Comparing Primary Coronary Angioplasty with Tissue-Plasminogen Activator for Acute Myocardial Infarction (GUSTO-IIb), NEJM 1997; 336: 1621-1628 Objectives: To

More information

Nature Genetics: doi: /ng Supplementary Figure 1

Nature Genetics: doi: /ng Supplementary Figure 1 Supplementary Figure 1 Illustrative example of ptdt using height The expected value of a child s polygenic risk score (PRS) for a trait is the average of maternal and paternal PRS values. For example,

More information

Update on Dyslipidemia and Recent Data on Treating the Statin Intolerant Patient

Update on Dyslipidemia and Recent Data on Treating the Statin Intolerant Patient Update on Dyslipidemia and Recent Data on Treating the Statin Intolerant Patient Steven E. Nissen MD Chairman, Department of Cardiovascular Medicine Cleveland Clinic Disclosure Consulting: Many pharmaceutical

More information

Cardiovascular Concerns in Intermediate Care

Cardiovascular Concerns in Intermediate Care Cardiovascular Concerns in Intermediate Care GINA ST. JEAN RN, MSN, CCRN-CSC CLINICAL NURSE EDUCATOR HEART AND & CRITICAL AND INTERMEDIATE CARE Objectives: Identify how to do a thorough assessment of the

More information

Genetics and the prevention of CAD

Genetics and the prevention of CAD Genetics and the prevention of CAD Presented by: Robert Roberts, MD, FRCPC, MACC, FAHA, FRSC Professor and Departmental Chair ISCTR University of Arizona College of Medicine Phoenix Past President and

More information

Regence. Medical Policy Manual. Date of Origin: May Topic: Genetic Testing for Lipoprotein(a) Variant(s) as a Decision Aid for Aspirin Treatment

Regence. Medical Policy Manual. Date of Origin: May Topic: Genetic Testing for Lipoprotein(a) Variant(s) as a Decision Aid for Aspirin Treatment Regence Medical Policy Manual Topic: Genetic Testing for Lipoprotein(a) Variant(s) as a Decision Aid for Aspirin Treatment Date of Origin: May 2013 Section: Genetic Testing Last Reviewed Date: June 2013

More information

Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies

Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies A Consensus Statement from the European Atherosclerosis Society

More information

Dietary priorities for type 2 diabetes

Dietary priorities for type 2 diabetes Dietary priorities for type 2 diabetes Edinburgh, 17 th July 2018 Nita Gandhi Forouhi MRC Epidemiology Unit, University of Cambridge MRC Epidemiology Unit World Congress on Prevention of Diabetes and its

More information

COURAGE to Leave Diseased Arteries Alone

COURAGE to Leave Diseased Arteries Alone COURAGE to Leave Diseased Arteries Alone Spencer King MD MACC, FSCAI St. Joseph s s Heart and Vascular Institute Professor of Medicine Emeritus Emory Univ. Atlanta, USA Conflict: I am an Interventionalist

More information

Explore a Trait Assignment Heart Disease Scenario

Explore a Trait Assignment Heart Disease Scenario Explore a Trait Assignment Heart Disease Scenario 1. After reading the 23AndMe Facts on Heart Disease provided below, write a one-paragraph summary in your own words of the information provided. Include

More information

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized

More information

Drug Class Review HMG-CoA Reductase Inhibitors (Statins) and Fixed-dose Combination Products Containing a Statin

Drug Class Review HMG-CoA Reductase Inhibitors (Statins) and Fixed-dose Combination Products Containing a Statin Drug Class Review HMG-CoA Reductase Inhibitors (Statins) and Fixed-dose Combination Products Containing a Statin Final Report Update 5 November 2009 This report reviews information about the comparative

More information

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION 2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL

More information

CS2220 Introduction to Computational Biology

CS2220 Introduction to Computational Biology CS2220 Introduction to Computational Biology WEEK 8: GENOME-WIDE ASSOCIATION STUDIES (GWAS) 1 Dr. Mengling FENG Institute for Infocomm Research Massachusetts Institute of Technology mfeng@mit.edu PLANS

More information

Calcium Supplementation

Calcium Supplementation University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2016 Calcium Supplementation Jani M. Kim University of Vermont College of Medicine Follow

More information

CVD risk estimation in populations with high prevalence of MetS. Dilek Ural, 12 March 2017 Koç University, Istanbul

CVD risk estimation in populations with high prevalence of MetS. Dilek Ural, 12 March 2017 Koç University, Istanbul CVD risk estimation in populations with high prevalence of MetS Dilek Ural, 12 March 2017 Koç University, Istanbul Understanding CV risk Likelihood of a person developing an atherosclerotic CV event over

More information

Biostatistics and Epidemiology Step 1 Sample Questions Set 2. Diagnostic and Screening Tests

Biostatistics and Epidemiology Step 1 Sample Questions Set 2. Diagnostic and Screening Tests Biostatistics and Epidemiology Step 1 Sample Questions Set 2 Diagnostic and Screening Tests 1. A rare disorder of amino acid metabolism causes severe mental retardation if left untreated. If the disease

More information

Institute of Medical Epidemiology, Biostatistics, and Informatics, University of Halle-Wittenberg, Halle (Saale) 2

Institute of Medical Epidemiology, Biostatistics, and Informatics, University of Halle-Wittenberg, Halle (Saale) 2 Do Randomized and Non-Randomized Trials Yield Different Answers in Similar Populations? Evidence from a 'Meta-Propensity Score' Analysis in Cardiac Surgery Kuss O 1, Legler T 1, Börgermann J 2 1 Institute

More information

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Biases in clinical research Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Learning objectives Describe the threats to causal inferences in clinical studies Understand the role of

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al. Comparative

More information

University of Bristol - Explore Bristol Research

University of Bristol - Explore Bristol Research Carreras-Torres, R., Johansson, M., Gaborieau, V., Haycock, P., Wade, K., Relton, C.,... Brennan, P. (2017). The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian

More information

CVD risk assessment using risk scores in primary and secondary prevention

CVD risk assessment using risk scores in primary and secondary prevention CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities

More information

This event does not qualify for continuing medical education (CME), continuing nursing education (CNE), or continuing education (CE) credit

This event does not qualify for continuing medical education (CME), continuing nursing education (CNE), or continuing education (CE) credit Welcome to this program sponsored by AstraZeneca The educator, who is presenting on behalf of AstraZeneca, is here to provide educational information pertinent to understanding the risk of a recurrent

More information

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial investigators

More information

Cost effectiveness of statin therapy for the primary prevention of coronary heart disease in Ireland Nash A, Barry M, Walshe V

Cost effectiveness of statin therapy for the primary prevention of coronary heart disease in Ireland Nash A, Barry M, Walshe V Cost effectiveness of statin therapy for the primary prevention of coronary heart disease in Ireland Nash A, Barry M, Walshe V Record Status This is a critical abstract of an economic evaluation that meets

More information

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY MCC-006 POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) 00269 Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note : There will be multiple

More information

Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona,

Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona, Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona, Jamaica At the end of this presentation the participant

More information